A detailed history of Wasatch Advisors Inc transactions in Cerus Corp stock. As of the latest transaction made, Wasatch Advisors Inc holds 6,284,104 shares of CERS stock, worth $11.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,284,104
Previous 6,530,019 3.77%
Holding current value
$11.2 Million
Previous $14.1 Million 15.8%
% of portfolio
0.06%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$1.66 - $2.42 $408,218 - $595,114
-245,915 Reduced 3.77%
6,284,104 $11.9 Million
Q4 2023

Feb 14, 2024

BUY
$1.25 - $2.35 $821,213 - $1.54 Million
656,971 Added 11.19%
6,530,019 $14.1 Million
Q2 2023

Aug 07, 2023

BUY
$1.79 - $2.9 $1.53 Million - $2.48 Million
854,609 Added 17.03%
5,873,048 $14.4 Million
Q1 2023

May 12, 2023

BUY
$2.65 - $3.81 $406,711 - $584,743
153,476 Added 3.15%
5,018,439 $14.9 Million
Q4 2022

Feb 14, 2023

SELL
$3.38 - $4.22 $1.55 Million - $1.94 Million
-458,549 Reduced 8.61%
4,864,963 $17.8 Million
Q3 2022

Nov 14, 2022

BUY
$3.43 - $5.83 $2.48 Million - $4.21 Million
721,755 Added 15.68%
5,323,512 $19.2 Million
Q2 2022

Aug 12, 2022

SELL
$4.41 - $5.69 $16.9 Million - $21.8 Million
-3,823,851 Reduced 45.38%
4,601,757 $24.3 Million
Q1 2022

May 13, 2022

BUY
$4.81 - $6.99 $1.14 Million - $1.66 Million
236,787 Added 2.89%
8,425,608 $46.3 Million
Q4 2021

Feb 15, 2022

SELL
$5.97 - $7.93 $79,800 - $106,000
-13,367 Reduced 0.16%
8,188,821 $55.8 Million
Q3 2021

Nov 12, 2021

BUY
$4.79 - $6.68 $3.45 Million - $4.81 Million
719,561 Added 9.62%
8,202,188 $50 Million
Q2 2021

Aug 12, 2021

BUY
$5.35 - $6.35 $7.81 Million - $9.27 Million
1,459,666 Added 24.24%
7,482,627 $44.2 Million
Q1 2021

May 10, 2021

BUY
$5.68 - $7.87 $17.4 Million - $24.1 Million
3,062,266 Added 103.43%
6,022,961 $36.2 Million
Q4 2020

Feb 12, 2021

BUY
$5.25 - $8.56 $15.5 Million - $25.3 Million
2,960,695 New
2,960,695 $20.5 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.